Primary surgery in ovarian cancer: current opinions

Research output: Contribution to journalReview article


There have been no controlled clinical trials supporting the use of primary cytoreductive surgery. The question remains as to whether the observed survival benefits for patients subjected to primary cytoreductive surgery are an effect of surgical skill or tumour biology. The proponents of tumour biology claim that cytoreductive surgery is a selective procedure, choosing patients with better prognosis. This paper discusses indirect evidence in the literature in support of, or in contradiction to, this hypothesis.


External organisations
  • Skåne University Hospital
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Cancer and Oncology


  • Female, Humans, Ovarian Neoplasms/mortality, Survival Rate
Original languageEnglish
Pages (from-to)95-100
Number of pages6
JournalAnnals of Medicine
Issue number1
Publication statusPublished - 1995 Feb
Publication categoryResearch
Externally publishedYes